4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5(3)-(6-methylpyridin-2-yl)imidazole and -pyrazole derivatives as potent and selective inhibitors of transforming growth factor-β type I receptor kinase
Keywords: TGF-β; ALK5 inhibitor; Fibrosis; Cancer; Kinase assay; Cell-based luciferase reporter assay; Docking;